{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:04:15Z","timestamp":1785369855342,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["BE5347\/4-1"],"award-info":[{"award-number":["BE5347\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbamcr.2025.120062","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T07:46:36Z","timestamp":1759218396000},"page":"120062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer"],"prefix":"10.1016","volume":"1873","author":[{"given":"Neele","family":"W\u00fcstmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julissa","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Vieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Humberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Schlack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"B\u00f6gemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres Jan","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Bernemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.bbamcr.2025.120062_bb0005","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.bbamcr.2025.120062_bb0010","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bbamcr.2025.120062_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbamcr.2025.120062_bb0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.bbamcr.2025.120062_bb0025","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa1815671","article-title":"Darolutamide in nonmetastatic, castration-resistant prostate cancer","volume":"380","author":"Fizazi","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120062_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41585-021-00438-4","article-title":"Resistance to second-generation androgen receptor antagonists in prostate cancer","volume":"18","author":"Schmidt","year":"2021","journal-title":"Nat. Rev. Urol."},{"issue":"11","key":"10.1016\/j.bbamcr.2025.120062_bb0035","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.bbamcr.2025.120062_bb0040","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1158\/1078-0432.CCR-18-4276","article-title":"Comparative analysis of AR variant AR-V567es mRNA detection systems reveals eminent variability and questions the role as a clinical biomarker in prostate cancer","volume":"25","author":"Bernemann","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120062_bb0045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1172\/JCI122819","article-title":"Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer","volume":"129","author":"Sharp","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120062_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16094-6","article-title":"Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients","volume":"12","author":"Schlack","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120062_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40364-023-00481-w","article-title":"Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer","volume":"11","author":"Wustmann","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.bbamcr.2025.120062_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biocel.2014.06.013","article-title":"Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells","volume":"54","author":"Krause","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120062_bb0065","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa227","article-title":"Isoform-specific activities of androgen receptor and its splice variants in prostate cancer cells","volume":"162","author":"Nagandla","year":"2021","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120062_bb0070","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1038\/s41598-022-09371-x","article-title":"Cistrome and transcriptome analysis identifies unique androgen receptor (AR) and AR-V7 splice variant chromatin binding and transcriptional activities","volume":"12","author":"Basil","year":"2022","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.bbamcr.2025.120062_bb0075","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1158\/0008-5472.CAN-11-3892","article-title":"Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer","volume":"72","author":"Hu","year":"2012","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbamcr.2025.120062_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063466","article-title":"Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells","volume":"8","author":"Cottard","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbamcr.2025.120062_bb0085","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Guo","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120062_bb0090","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccell.2019.01.008","article-title":"ARv7 represses tumor-suppressor genes in castration-resistant prostate cancer","volume":"35","author":"Cato","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120062_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100915","article-title":"Identification of AR-V7 downstream genes commonly targeted by AR\/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer","volume":"14","author":"Sugiura","year":"2021","journal-title":"Transl. Oncol."},{"issue":"11","key":"10.1016\/j.bbamcr.2025.120062_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027970","article-title":"Androgen receptor variants occur frequently in castration resistant prostate cancer metastases","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120062_bb0105","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.3934\/mbe.2021158","article-title":"Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis","volume":"18","author":"Gu","year":"2021","journal-title":"Math. Biosci. Eng."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120062_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019059","article-title":"Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival","volume":"6","author":"Hornberg","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120062_bb0115","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.3892\/mmr.2014.3097","article-title":"Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1\/2-mediated matrix metalloproteinase-3 secretion","volume":"11","author":"Chen","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120062_bb0120","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/nar\/gkx1306","article-title":"Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer","volume":"46","author":"He","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.bbamcr.2025.120062_bb0125","doi-asserted-by":"crossref","first-page":"729","DOI":"10.21037\/atm.2019.11.127","article-title":"Restoration of FKBP51 protein promotes the progression of castration resistant prostate cancer","volume":"7","author":"Yu","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120062_bb0130","first-page":"188","article-title":"Predictive and targeting value of IGFBP-3 in therapeutically resistant prostate cancer","volume":"7","author":"Hensley","year":"2019","journal-title":"Am. J. Clin. Exp. Urol."},{"issue":"6","key":"10.1016\/j.bbamcr.2025.120062_bb0135","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1210\/en.2006-1653","article-title":"Identification of androgen response elements in the insulin-like growth factor I upstream promoter","volume":"148","author":"Wu","year":"2007","journal-title":"Endocrinology"},{"issue":"24","key":"10.1016\/j.bbamcr.2025.120062_bb0140","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/onc.2013.284","article-title":"Mechanisms of the androgen receptor splicing in prostate cancer cells","volume":"33","author":"Liu","year":"2014","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbamcr.2025.120062_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molcel.2018.08.029","article-title":"ZFX mediates non-canonical oncogenic functions of the androgen receptor splice variant 7 in castrate-resistant prostate cancer","volume":"72","author":"Cai","year":"2018","journal-title":"Mol. Cell"},{"issue":"39","key":"10.1016\/j.bbamcr.2025.120062_bb0150","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1073\/pnas.1012443107","article-title":"Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor","volume":"107","author":"Watson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.bbamcr.2025.120062_bb0155","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1158\/1078-0432.CCR-17-0017","article-title":"Androgen receptor variant AR-V9 is coexpressed with AR-V7 in prostate cancer metastases and predicts abiraterone resistance","volume":"23","author":"Kohli","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbamcr.2025.120062_bb0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41416-018-0172-0","article-title":"Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases","volume":"119","author":"Kallio","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"15","key":"10.1016\/j.bbamcr.2025.120062_bb0165","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.bbamcr.2025.120062_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"issue":"21","key":"10.1016\/j.bbamcr.2025.120062_bb0175","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","article-title":"A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data","volume":"27","author":"Li","year":"2011","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.bbamcr.2025.120062_bb0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.bbamcr.2025.120062_bb0185","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbamcr.2025.120062_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.102142","article-title":"Enhancing biomarker detection in cancer: a comparative analysis of pre-analytical reverse transcription enzymes for liquid biopsy application","author":"Wustmann","year":"2024","journal-title":"Lab. Investig."},{"issue":"15","key":"10.1016\/j.bbamcr.2025.120062_bb0195","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/pros.21382","article-title":"A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities","volume":"71","author":"Hu","year":"2011","journal-title":"Prostate"},{"issue":"13","key":"10.1016\/j.bbamcr.2025.120062_bb0200","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1158\/0008-5472.CAN-08-0594","article-title":"Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance","volume":"68","author":"Dehm","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120062_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","article-title":"Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2025.120062_bb0210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12935-025-03948-y","article-title":"Molecular analysis of androgen receptor splice variant AR-V3 reveals eminent ambiguity regarding activity and clinical utility","volume":"25","author":"Wustmann","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbamcr.2025.120062_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.972572","article-title":"Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer","volume":"12","author":"Pak","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2025.120062_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2020.12.037","article-title":"Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapy","volume":"504","author":"Ma","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbamcr.2025.120062_bb0225","first-page":"4","article-title":"Prospective multicenter study of circulating tumor cell AR-V7 and taxane versus hormonal treatment outcomes in metastatic castration-resistant prostate cancer","author":"Armstrong","year":"2020","journal-title":"JCO Precis. Oncol."},{"issue":"11","key":"10.1016\/j.bbamcr.2025.120062_bb0230","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/jamaoncol.2016.1828","article-title":"Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer","volume":"2","author":"Scher","year":"2016","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.bbamcr.2025.120062_bb0235","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.eururo.2016.11.024","article-title":"Nuclear-specific AR-V7 protein localization is necessary to guide treatment selection in metastatic castration-resistant prostate cancer","volume":"71","author":"Scher","year":"2017","journal-title":"Eur. Urol."},{"issue":"9","key":"10.1016\/j.bbamcr.2025.120062_bb0240","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jamaoncol.2018.1621","article-title":"Assessment of the validity of nuclear-localized androgen receptor splice variant 7 in circulating tumor cells as a predictive biomarker for castration-resistant prostate cancer","volume":"4","author":"Scher","year":"2018","journal-title":"JAMA Oncol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488925001673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:09:39Z","timestamp":1764133779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488925001673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0167488925001673"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120062","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2025.120062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120062"}}